Načítá se...
Pharmacogenomics of Cognitive Dysfunction and Neuropsychiatric Disorders in Dementia
Symptomatic interventions for patients with dementia involve anti-dementia drugs to improve cognition, psychotropic drugs for the treatment of behavioral disorders (BDs), and different categories of drugs for concomitant disorders. Demented patients may take >6–10 drugs/day with the consequent ri...
Uloženo v:
| Vydáno v: | Int J Mol Sci |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
MDPI
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7246738/ https://ncbi.nlm.nih.gov/pubmed/32357528 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms21093059 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|